New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Curaleaf Holdings, Inc.
CURLF
Shape
US Flag

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

3B

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

3B

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

3.41USD
Shape0.01 ( 0.29%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

47%

Quote Panel

Shape
Updated October 28, 2024
1W -3.94 % 1M 11.44 % 3M -14.54 % 1Y 30.65 %

Key Metrics

Shape
  • Market Cap

    2.54B


  • Shares Outstanding

    743.77M


  • Share in Float

    516.17M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    3.41


  • Average Volume

    414453


  • Beta

    1.507


  • Range

    2.51-6.4


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.curaleaf.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.85x

P/S Ratio

2.54x

P/B Ratio

0.6

Debt/Equity

-18.6%

Net Margin

$-0.3

EPS

How CURLF compares to sector?

P/E Ratio

Relative Strength

Shape

CURLF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape351%

2025-Revenue

$0.16

Shape-144%

2025-EPS

$277M

Shape334%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Wedbush

initialise

Previous: Not converted

2022-12-02

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.07
vs -0.08

Q4.22

arrow
arrow

N/A

-0.38
vs -0.04

Q1.23

arrow
arrow

N/A

-0.05
vs -0.03

Q2.23

arrow
arrow

N/A

-0.07
vs -0.04

Q3.23

arrow
arrow

N/A

-0.09
vs -0.07

Q4.23

arrow
arrow

N/A

-0.09
vs -0.38

Q1.24

arrow
arrow

N/A

-0.07
vs -0.05

Q2.24

arrow
arrow

N/A

-0.06
vs -0.07

Q3.24

arrow
arrow

N/A

-0.06
vs -0.09

Q4.24

arrow
arrow

N/A

-0.05
vs -0.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+7%

339.7M  vs 317.1M

Q4.22

arrow
arrow

+8%

346M  vs 320M

Q1.23

arrow
arrow

+7%

336.5M  vs 313.1M

Q2.23

arrow
arrow

+0%

338.6M  vs 337.6M

Q3.23

arrow
arrow

-2%

333.2M  vs 339.7M

Q4.23

arrow
arrow

+3%

354.8M  vs 346M

Q1.24

arrow
arrow

+0%

337.4M  vs 336.5M

Q2.24

arrow
arrow

+1%

342.2M  vs 338.6M

Q3.24

arrow
arrow

+4%

347.8M  vs 333.2M

Q4.24

arrow
arrow

+1%

359.9M  vs 354.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.02

Q4.22

arrow
arrow

-21%

-0.21
vs -0.03

Q1.23

arrow
arrow

-4%

-0.04
vs -0.21

Q2.23

arrow
arrow

-6%

-0.06
vs -0.04

Q3.23

arrow
arrow

-8%

-0.08
vs -0.06

Q4.23

arrow
arrow

-6%

-0.06
vs -0.08

Q1.24

arrow
arrow

-5%

-0.05
vs -0.06

Q2.24

arrow
arrow

-5%

-0.05
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

13

13
vs 15

-13%

Q4.22

arrow
arrow

14

14
vs 13

8%

Q1.23

arrow
arrow

13

13
vs 14

-7%

Q2.23

arrow
arrow

15

15
vs 13

15%

Q3.23

arrow
arrow

11

11
vs 15

-27%

Q4.23

arrow
arrow

12

12
vs 11

9%

Q1.24

arrow
arrow

11

11
vs 12

-8%

Q2.24

arrow
arrow

12

12
vs 11

9%

Earnings Growth

Latest News